Cargando…

Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF

BACKGROUND: The purpose of this study was to clarify the prevalence, association with frailty and exercise capacity, and prognostic implication of sarcopenic obesity in patients with heart failure. METHODS: The present study included 779 older adults hospitalized with heart failure (median age: 81 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Hiroshi, Matsue, Yuya, Kamiya, Kentaro, Kagiyama, Nobuyuki, Maeda, Daichi, Endo, Yoshiko, Ueno, Hidenao, Yoshioka, Kenji, Mizukami, Akira, Saito, Kazuya, Ogasahara, Yuki, Maekawa, Emi, Konishi, Masaaki, Kitai, Takeshi, Iwata, Kentaro, Jujo, Kentaro, Wada, Hiroshi, Hiki, Masaru, Dotare, Taishi, Sunayama, Tsutomu, Kasai, Takatoshi, Nagamatsu, Hirofumi, Ozawa, Tetsuya, Izawa, Katsuya, Yamamoto, Shuhei, Aizawa, Naoki, Wakaume, Kazuki, Oka, Kazuhiro, Momomura, Shin-ichi, Minamino, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254413/
https://www.ncbi.nlm.nih.gov/pubmed/35787667
http://dx.doi.org/10.1186/s12877-022-03168-3
_version_ 1784740693532475392
author Saito, Hiroshi
Matsue, Yuya
Kamiya, Kentaro
Kagiyama, Nobuyuki
Maeda, Daichi
Endo, Yoshiko
Ueno, Hidenao
Yoshioka, Kenji
Mizukami, Akira
Saito, Kazuya
Ogasahara, Yuki
Maekawa, Emi
Konishi, Masaaki
Kitai, Takeshi
Iwata, Kentaro
Jujo, Kentaro
Wada, Hiroshi
Hiki, Masaru
Dotare, Taishi
Sunayama, Tsutomu
Kasai, Takatoshi
Nagamatsu, Hirofumi
Ozawa, Tetsuya
Izawa, Katsuya
Yamamoto, Shuhei
Aizawa, Naoki
Wakaume, Kazuki
Oka, Kazuhiro
Momomura, Shin-ichi
Minamino, Tohru
author_facet Saito, Hiroshi
Matsue, Yuya
Kamiya, Kentaro
Kagiyama, Nobuyuki
Maeda, Daichi
Endo, Yoshiko
Ueno, Hidenao
Yoshioka, Kenji
Mizukami, Akira
Saito, Kazuya
Ogasahara, Yuki
Maekawa, Emi
Konishi, Masaaki
Kitai, Takeshi
Iwata, Kentaro
Jujo, Kentaro
Wada, Hiroshi
Hiki, Masaru
Dotare, Taishi
Sunayama, Tsutomu
Kasai, Takatoshi
Nagamatsu, Hirofumi
Ozawa, Tetsuya
Izawa, Katsuya
Yamamoto, Shuhei
Aizawa, Naoki
Wakaume, Kazuki
Oka, Kazuhiro
Momomura, Shin-ichi
Minamino, Tohru
author_sort Saito, Hiroshi
collection PubMed
description BACKGROUND: The purpose of this study was to clarify the prevalence, association with frailty and exercise capacity, and prognostic implication of sarcopenic obesity in patients with heart failure. METHODS: The present study included 779 older adults hospitalized with heart failure (median age: 81 years; 57.4% men). Sarcopenia was diagnosed based on the guidelines by the Asian Working Group for Sarcopenia. Obesity was defined as the percentage of body fat mass (FM) obtained by bioelectrical impedance analysis. The FM cut-off points for obesity were 38% for women and 27% for men. The primary endpoint was 1-year all-cause death. We assessed the associations of sarcopenic obesity occurrence with the short physical performance battery (SPPB) score and 6-minute walk distance (6MWD). RESULTS: The rates of sarcopenia and obesity were 19.3 and 26.2%, respectively. The patients were classified into the following groups: non-sarcopenia/non-obesity (58.5%), non-sarcopenia/obesity (22.2%), sarcopenia/non-obesity (15.3%), and sarcopenia/obesity (4.0%). The sarcopenia/obesity group had a lower SPPB score and shorter 6MWD, which was independent of age and sex (coefficient, − 0.120; t-value, − 3.74; P < 0.001 and coefficient, − 77.42; t-value, − 3.61; P < 0.001; respectively). Ninety-six patients died during the 1-year follow-up period. In a Cox proportional hazard analysis, sarcopenia and obesity together were an independent prognostic factor even after adjusting for a coexisting prognostic factor (non-sarcopenia/non-obesity vs. sarcopenia/obesity: hazard ratio, 2.48; 95% confidence interval, 1.22–5.04; P = 0.012). CONCLUSION: Sarcopenic obesity is a risk factor for all-cause death and low physical function in older adults with heart failure. TRIAL REGISTRATION: University Hospital Information Network (UMIN-CTR: UMIN000023929). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-03168-3.
format Online
Article
Text
id pubmed-9254413
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92544132022-07-06 Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF Saito, Hiroshi Matsue, Yuya Kamiya, Kentaro Kagiyama, Nobuyuki Maeda, Daichi Endo, Yoshiko Ueno, Hidenao Yoshioka, Kenji Mizukami, Akira Saito, Kazuya Ogasahara, Yuki Maekawa, Emi Konishi, Masaaki Kitai, Takeshi Iwata, Kentaro Jujo, Kentaro Wada, Hiroshi Hiki, Masaru Dotare, Taishi Sunayama, Tsutomu Kasai, Takatoshi Nagamatsu, Hirofumi Ozawa, Tetsuya Izawa, Katsuya Yamamoto, Shuhei Aizawa, Naoki Wakaume, Kazuki Oka, Kazuhiro Momomura, Shin-ichi Minamino, Tohru BMC Geriatr Research BACKGROUND: The purpose of this study was to clarify the prevalence, association with frailty and exercise capacity, and prognostic implication of sarcopenic obesity in patients with heart failure. METHODS: The present study included 779 older adults hospitalized with heart failure (median age: 81 years; 57.4% men). Sarcopenia was diagnosed based on the guidelines by the Asian Working Group for Sarcopenia. Obesity was defined as the percentage of body fat mass (FM) obtained by bioelectrical impedance analysis. The FM cut-off points for obesity were 38% for women and 27% for men. The primary endpoint was 1-year all-cause death. We assessed the associations of sarcopenic obesity occurrence with the short physical performance battery (SPPB) score and 6-minute walk distance (6MWD). RESULTS: The rates of sarcopenia and obesity were 19.3 and 26.2%, respectively. The patients were classified into the following groups: non-sarcopenia/non-obesity (58.5%), non-sarcopenia/obesity (22.2%), sarcopenia/non-obesity (15.3%), and sarcopenia/obesity (4.0%). The sarcopenia/obesity group had a lower SPPB score and shorter 6MWD, which was independent of age and sex (coefficient, − 0.120; t-value, − 3.74; P < 0.001 and coefficient, − 77.42; t-value, − 3.61; P < 0.001; respectively). Ninety-six patients died during the 1-year follow-up period. In a Cox proportional hazard analysis, sarcopenia and obesity together were an independent prognostic factor even after adjusting for a coexisting prognostic factor (non-sarcopenia/non-obesity vs. sarcopenia/obesity: hazard ratio, 2.48; 95% confidence interval, 1.22–5.04; P = 0.012). CONCLUSION: Sarcopenic obesity is a risk factor for all-cause death and low physical function in older adults with heart failure. TRIAL REGISTRATION: University Hospital Information Network (UMIN-CTR: UMIN000023929). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-03168-3. BioMed Central 2022-07-05 /pmc/articles/PMC9254413/ /pubmed/35787667 http://dx.doi.org/10.1186/s12877-022-03168-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Saito, Hiroshi
Matsue, Yuya
Kamiya, Kentaro
Kagiyama, Nobuyuki
Maeda, Daichi
Endo, Yoshiko
Ueno, Hidenao
Yoshioka, Kenji
Mizukami, Akira
Saito, Kazuya
Ogasahara, Yuki
Maekawa, Emi
Konishi, Masaaki
Kitai, Takeshi
Iwata, Kentaro
Jujo, Kentaro
Wada, Hiroshi
Hiki, Masaru
Dotare, Taishi
Sunayama, Tsutomu
Kasai, Takatoshi
Nagamatsu, Hirofumi
Ozawa, Tetsuya
Izawa, Katsuya
Yamamoto, Shuhei
Aizawa, Naoki
Wakaume, Kazuki
Oka, Kazuhiro
Momomura, Shin-ichi
Minamino, Tohru
Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
title Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
title_full Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
title_fullStr Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
title_full_unstemmed Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
title_short Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
title_sort sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from fragile-hf
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254413/
https://www.ncbi.nlm.nih.gov/pubmed/35787667
http://dx.doi.org/10.1186/s12877-022-03168-3
work_keys_str_mv AT saitohiroshi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT matsueyuya sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT kamiyakentaro sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT kagiyamanobuyuki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT maedadaichi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT endoyoshiko sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT uenohidenao sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT yoshiokakenji sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT mizukamiakira sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT saitokazuya sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT ogasaharayuki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT maekawaemi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT konishimasaaki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT kitaitakeshi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT iwatakentaro sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT jujokentaro sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT wadahiroshi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT hikimasaru sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT dotaretaishi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT sunayamatsutomu sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT kasaitakatoshi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT nagamatsuhirofumi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT ozawatetsuya sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT izawakatsuya sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT yamamotoshuhei sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT aizawanaoki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT wakaumekazuki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT okakazuhiro sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT momomurashinichi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf
AT minaminotohru sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf